Cargando…
Adjuvant probiotic Bifidobacterium animalis subsp. lactis CP-9 improve phototherapeutic treatment outcomes in neonatal jaundice among full-term newborns: A randomized double-blind clinical study
Probiotics had been used to decreased bilirubin level in neonatal jaundice (NJ) without being further studied mechanism and stratification. The intestinal pathogen Escherichia coli produced β-glucuronidase would increase enterohepatic circulation and elevate serum bilirubin levels (SBLs) which might...
Autores principales: | Tsai, Ming-Luen, Lin, Wen-Yang, Chen, Yin-Ting, Lin, Hsiang-Yu, Ho, Hsieh-Hsun, Kuo, Yi-Wei, Lin, Jia-Hung, Huang, Yen-Yu, Wang, Hui-Shan, Chiu, Hsiao-Yu, Lin, Hung-Chih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666203/ https://www.ncbi.nlm.nih.gov/pubmed/36397441 http://dx.doi.org/10.1097/MD.0000000000031030 |
Ejemplares similares
-
The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®)
por: Jungersen, Mikkel, et al.
Publicado: (2014) -
Use of the Probiotic Bifidobacterium animalis subsp. lactis HN019 in Oral Diseases
por: Araujo, Lisa Danielly Curcino, et al.
Publicado: (2022) -
Adjuvant Probiotics of Lactobacillus salivarius subsp. salicinius AP-32, L. johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9 Attenuate Glycemic Levels and Inflammatory Cytokines in Patients With Type 1 Diabetes Mellitus
por: Wang, Chung-Hsing, et al.
Publicado: (2022) -
Updated Genome Sequence for the Probiotic Bacterium Bifidobacterium animalis subsp. lactis BB-12
por: Jensen, Kristian, et al.
Publicado: (2021) -
Transcriptional and Functional Analysis of Bifidobacterium animalis subsp. lactis Exposure to Tetracycline
por: Morovic, Wesley, et al.
Publicado: (2018)